141 related articles for article (PubMed ID: 35753955)
21. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
22. Definitive chemoradiation in nonmetastatic squamous cell carcinoma anal canal: A single-institution experience.
Kumar V; Bansal S; Badola A; Nautiyal V; Gupta M; Ahmad M; Saini S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S405-S409. PubMed ID: 36510995
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
24. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer.
Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
[TBL] [Abstract][Full Text] [Related]
25. Anal squamous cell carcinoma: are we improving outcomes?
Mackowski A; Levitt M; Makin G; Salama P; Tan P; Penter C; Platell C
ANZ J Surg; 2018 Oct; 88(10):1013-1016. PubMed ID: 30159994
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.
Ghareeb A; Paramasevon K; Mokool P; van der Voet H; Jha M
Ann R Coll Surg Engl; 2019 Mar; 101(3):168-175. PubMed ID: 30482037
[TBL] [Abstract][Full Text] [Related]
27. Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma.
Youssef I; Osborn V; Lee A; Katsoulakis E; Kavi A; Choi K; Safdieh J; Schreiber D
J Gastrointest Oncol; 2019 Aug; 10(4):616-622. PubMed ID: 31392041
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
[TBL] [Abstract][Full Text] [Related]
30. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
31. Factors Associated With Chemoradiation Therapy Interruption and Noncompletion Among Patients With Squamous Cell Anal Carcinoma.
Raphael MJ; Ko G; Booth CM; Brogly SB; Li W; Kalyvas M; Hanna TP; Patel SV
JAMA Oncol; 2020 Jun; 6(6):881-887. PubMed ID: 32324199
[TBL] [Abstract][Full Text] [Related]
32. Sphincter preservation in anal cancer: a brief review.
Khosla D; Kumar R; Kapoor R; Sharma SC
Saudi J Gastroenterol; 2013; 19(3):101-7. PubMed ID: 23680706
[TBL] [Abstract][Full Text] [Related]
33. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus.
Ruano APC; de Jesus Ferreira Costa D; Braun AC; Torres JA; Barbosa PHP; Abdallah EA; Barberan C; Souza E Silva V; Bovolim G; Buim MEC; da Silva Alves V; Riechelmann RP; Chinen LTD
Pathol Res Pract; 2023 Mar; 243():154327. PubMed ID: 36731178
[TBL] [Abstract][Full Text] [Related]
34. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
[TBL] [Abstract][Full Text] [Related]
35. Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy.
Bogach J; Fenech D; Chu W; Ashamalla S; Ung Y; Taggar AS; Chan KKW; Earle CC; Wong CS
Cancer Treat Res Commun; 2021; 26():100287. PubMed ID: 33360327
[TBL] [Abstract][Full Text] [Related]
36. Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.
Ponce SEB; Erickson BA; Hall WA; Bedi M; Martens MJ; Siker M; Thomas J; George B; Ludwig K; Peterson C; Ridolfi T; Longo JM
J Gastrointest Oncol; 2022 Feb; 13(1):185-196. PubMed ID: 35284138
[TBL] [Abstract][Full Text] [Related]
37. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
Flam M; John M; Pajak TF; Petrelli N; Myerson R; Doggett S; Quivey J; Rotman M; Kerman H; Coia L; Murray K
J Clin Oncol; 1996 Sep; 14(9):2527-39. PubMed ID: 8823332
[TBL] [Abstract][Full Text] [Related]
38. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.
Koerber SA; Slynko A; Haefner MF; Krug D; Schoneweg C; Kessel K; Kopp-Schneider A; Herfarth K; Debus J; Sterzing F
Radiat Oncol; 2014 May; 9():113. PubMed ID: 24886574
[TBL] [Abstract][Full Text] [Related]
40. [Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal].
Karasawa H; Ohnuma S; Watanabe K; Tsuchiya T; Imoto H; Aoki T; Kudoh K; Tanaka N; Nagao M; Abe T; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2009-2010. PubMed ID: 29394850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
